Predictive value of antral follicle count and serum anti-Mullerian hormone: Which is better for live birth prediction in patients aged over 40 with their first IVF treatment?

被引:15
|
作者
Lee, Yubin [1 ,2 ]
Kim, Tae Hyung [1 ]
Park, Jae Kyun [1 ]
Eum, Jin Hee [1 ]
Lee, Hee Jun [1 ]
Kim, Jayeon [1 ,2 ]
Lyu, Sang Woo [1 ]
Kim, You Shin [1 ,2 ]
Lee, Woo Sik [1 ]
Yoon, Tae Ki [1 ,2 ]
机构
[1] CHA Univ, CHA Gangnam Med Ctr, Fertil Ctr, Dept Obstet & Gynecol, Seoul, South Korea
[2] CHA Fertil Ctr, Seoul Stn, Seoul, South Korea
关键词
Antral follicle count; Aged; In vitro fertilization; Clinical pregnancy; Live birth; IN-VITRO FERTILIZATION; POOR OVARIAN RESPONSE; ASSISTED REPRODUCTIVE TECHNOLOGY; ANTIMULLERIAN HORMONE; CYCLE CANCELLATION; RESERVE; WOMEN; PREGNANCY; RATES;
D O I
10.1016/j.ejogrb.2017.12.047
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To evaluate clinical utility of antral follicle count (AFC) and anti-Mullerian hormone (AMH) in predicting in vitro fertilization (IVF) outcomes among the patients over 40 years old in their first IVF cycles. Study design: Total 219 patients aged 40 or older who underwent their first IVF with gonadotropin-releasing hormone antagonist protocol from January 2013 to September 2014 in CHA Gangnam fertility center were retrospectively analyzed. AFC and serum samples were measured prior to IVF treatment. The main outcomes were clinical pregnancy rate and live birth. Results: 36 out of 219 patients achieved clinical pregnancy (16.4%) and 27 out of 219 patients delivered (12.3%). The receiver operating characteristic curve analysis to predict clinical pregnancy showed that both age and AFC equally had higher accuracy by area under the curve (AUC = 0.657, P < 0.01) than serum AMH (AUC 0.613, P = 0.03). The optimum cut-off value of age was <= 41 and that of AFC was >3 to predict clinical pregnancy. For the prediction of live birth, AFC had the highest accuracy (AUC 0.698, P < 0.01), followed by age (AUC 0.674, P < 0.01) and the number of total retrieved oocytes (AUC 0.620, P = 0.02). The optimum cut-off value of age was <= 41, that of AFC was >3 and that of the number of total retrieved oocytes were >6. With multivariate regression analysis, age and AMH were significantly correlated with clinical pregnancy (age, odds ratio [OR] 0.53, P < 0.01; AMH, OR 1.31, P = 0.04), whereas age and AFC were association with live birth significantly (age, OR 0.41, P < 0.01; AFC, OR 1.10, P = 0.02). Conclusion: In patients aged over 40, AFC and AMH were shown to be good biomarkers for the prediction of clinical pregnancy and live birth. Although AMH was positively correlated with clinical pregnancy and had no association with live birth, the predictive value of AFC and AMH were similar for both clinical pregnancy and live birth. To predict the live birth, age <= 41, AFC >3 and total retrieved oocytes >6 appeared to be meaningful. This study demonstrated the significance of AMH and AFC as predictors of clinical pregnancy and live birth for old aged women at their first IVF cycle with gonadotropin-releasing hormone antagonist protocol. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:151 / 155
页数:5
相关论文
共 50 条
  • [41] Serum anti-mullerian hormone and antral follicle count as predictors of ovarian reserve after laparoscopic management of endometriotic cysts
    Pados, G.
    Tsolakidis, D.
    Billi, H.
    Athanatos, D.
    Tarlatzis, B.
    HUMAN REPRODUCTION, 2011, 26 : I323 - I323
  • [42] Comparison of anti-Mullerian hormone and antral follicle count in the prediction of ovarian response: a systematic review and meta-analysis
    Liu, Yang
    Pan, Zhengmei
    Wu, Yanzhi
    Song, Jiamei
    Chen, Jingsi
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [43] Dehydroepiandrostendione sulphate and prediction of live birth after IVF in young women with low anti-Mullerian hormone concentration
    Alebic, Miro Simun
    Stojanovic, Natasa
    REPRODUCTIVE BIOMEDICINE ONLINE, 2014, 28 (02) : 191 - 197
  • [44] Preliminary study on anti-Mullerian hormone, antral follicle count, menstruation and lymphocyte subsets in systemic lupus erythematosus patients
    Girbash, Ehab F.
    Abdelwahab, Shaimaa M.
    Fahmi, Dalia S.
    Abdeldayem, Hussein M.
    Ghonaim, Rania
    Atta, Doaa S.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2022, 159 (01) : 129 - 135
  • [45] Prediction of Antral Follicle Count with the Automated Elecsys® Anti-Mullerian Hormone (AMH) Immunoassay in a Multi-Center Prospective Study
    Jacobs, Michael H.
    Reuter, Laura
    Baker, Valerie
    Craig, LaTasha B.
    Sakkas, Denny
    Surrey, Eric
    Doody, Kevin
    Jungheim, Emily
    Bayrak, Aykut B.
    Hund, Martin
    Verhagen-Kamerbeek, Wilma
    Pardue, Deborah
    Buck, Katharina
    Timm, Barbara
    REPRODUCTIVE SCIENCES, 2018, 25 : 252A - 252A
  • [46] Maternal serum concentration of anti-Mullerian hormone is a better predictor than basal follicle stimulating hormone of successful blastocysts development during IVF treatment
    Sadruddin, Sheela
    Barnett, Brian
    Ku, Lowell
    Havemann, Dara
    Mucowski, Sara
    Herrington, Richard
    Burggren, Warren
    PLOS ONE, 2020, 15 (10):
  • [47] INDIVIDUAL IVF CLINIC PERFORMANCE OF ANTI-MULLERIAN HORMONE AND ANTRAL FOLLICLE COUNT AS BIOMARKERS OF OVARIAN RESPONSE TO CONTROLLED OVARIAN STIMULATION IN MULTICENTRE TRIALS
    Nelson, S.
    Arce, J. -C.
    FERTILITY AND STERILITY, 2014, 102 (03) : E147 - E147
  • [48] Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-Mullerian hormone level and antral follicle count
    Li, H. W. R.
    Lee, V. C. Y.
    Lau, E. Y. L.
    Yeung, W. S. B.
    Ho, P. C.
    Ng, E. H. Y.
    HUMAN REPRODUCTION, 2014, 29 : 329 - 329
  • [49] Effect of cigarette smoking on serum anti-Mullerian hormone and antral follicle count in women seeking fertility treatment: a prospective cross-sectional study
    Bhide, Priya
    Timlick, Elizabeth
    Kulkarni, Abhijit
    Gudi, Anil
    Shah, Amit
    Homburg, Roy
    Acharya, Ganesh
    BMJ OPEN, 2022, 12 (03): : e049646
  • [50] Anti-Mullerian hormone and antral follicle count as predictors for embryo/oocyte cryopreservation cycle outcomes in breast cancer patients stimulated with letrozole and follicle stimulating hormone
    Lee, Sanghoon
    Ozkavukcu, Sinan
    Heytens, Elke
    Moy, Fred
    Alappat, Rose M.
    Oktay, Kutluk
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2011, 28 (07) : 651 - 656